4//SEC Filing
Layman Melissa 4
Accession 0001209191-21-006330
CIK 0001419600other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 8:19 PM ET
Size
7.0 KB
Accession
0001209191-21-006330
Insider Transaction Report
Form 4
Layman Melissa
Chief Commercial Officer
Transactions
- Sale
Common Stock
2021-01-28$12.55/sh−2,624$32,931→ 88,376 total - Award
Common Stock
2021-01-27+30,000→ 91,000 total
Footnotes (2)
- [F1]On April 1, 2020, the Reporting Person was granted 30,000 restricted stock units. The vesting of the shares under the restricted stock unit award was to be based on the achievement of a specified amount of 2020 revenues from ZILRETTA product sales established at the time of the Compensation Committee's approval of the restricted stock unit award. On January 27, 2021, the Compensation Committee certified the achievement of a specified amount of 2020 revenues from ZILRETTA product sales resulting in the commencement of vesting of 30,000 shares. The Reporting Person previously reported the restricted stock units in Table II of Form 4.
- [F2]Sale of shares to cover income tax withholding obligations associated with the vesting of a restricted stock unit award granted to the Reporting Person on April 1, 2020.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001806204
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 8:19 PM ET
- Size
- 7.0 KB